These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8432311

  • 1. Ca2+ channel blocking activity of lacidipine and amlodipine in A7r5 vascular smooth muscle cells.
    Spampinato S, Bachetti T, Carboni L, Ratti E, Van Amsterdam FT, Ferri S.
    Eur J Pharmacol; 1993 Jan 15; 244(2):139-44. PubMed ID: 8432311
    [Abstract] [Full Text] [Related]

  • 2. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
    Salomone S, Godfraind T.
    Br J Pharmacol; 1993 May 15; 109(1):100-6. PubMed ID: 8495233
    [Abstract] [Full Text] [Related]

  • 3. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
    Burges RA, Gardiner DG, Gwilt M, Higgins AJ, Blackburn KJ, Campbell SF, Cross PE, Stubbs JK.
    J Cardiovasc Pharmacol; 1987 Jan 15; 9(1):110-9. PubMed ID: 2434785
    [Abstract] [Full Text] [Related]

  • 4. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
    Quartaroli M, Gambini F, Tarter G, Micheli D, Trist DG, Gaviraghi G.
    J Cardiovasc Pharmacol; 1991 Sep 15; 18(3):326-36. PubMed ID: 1720831
    [Abstract] [Full Text] [Related]

  • 5. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
    Micheli D, Collodel A, Semeraro C, Gaviraghi G, Carpi C.
    J Cardiovasc Pharmacol; 1990 Apr 15; 15(4):666-75. PubMed ID: 1691398
    [Abstract] [Full Text] [Related]

  • 6. Effect of S-312, a new calcium channel blocker, on the 1,4-dihydropyridine binding sites in porcine basilar blood vessels and rat aortic smooth muscle cells.
    Mihara S, Fujimoto M.
    Jpn J Pharmacol; 1991 Jul 15; 56(3):249-59. PubMed ID: 1832726
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei C, Leonardi A, Testa R.
    Arzneimittelforschung; 1996 Jan 15; 46(1):15-24. PubMed ID: 8821512
    [Abstract] [Full Text] [Related]

  • 8. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues.
    Angelico P, Guarneri L, Leonardi A, Testa R.
    J Pharm Pharmacol; 1999 Jun 15; 51(6):709-14. PubMed ID: 10454048
    [Abstract] [Full Text] [Related]

  • 9. Functional interaction of lacidipine with calcium channels in vascular smooth muscle.
    Godfraind T, Salomone S.
    J Cardiovasc Pharmacol; 1991 Jun 15; 18 Suppl 11():S1-6. PubMed ID: 1725443
    [Abstract] [Full Text] [Related]

  • 10. Dihydropyridine-induced Ca2+ release from ryanodine-sensitive Ca2+ pools in human skeletal muscle cells.
    Weigl LG, Hohenegger M, Kress HG.
    J Physiol; 2000 Jun 01; 525 Pt 2(Pt 2):461-9. PubMed ID: 10835047
    [Abstract] [Full Text] [Related]

  • 11. The actions of azelnidipine, a dihydropyridine-derivative Ca antagonist, on voltage-dependent Ba2+ currents in guinea-pig vascular smooth muscle.
    Zhu HL, Tomoda T, Aishima M, Ito Y, Teramoto N.
    Br J Pharmacol; 2006 Nov 01; 149(6):786-96. PubMed ID: 17016499
    [Abstract] [Full Text] [Related]

  • 12. Effect of hydrogen peroxide on calcium homeostasis in smooth muscle cells.
    Roveri A, Coassin M, Maiorino M, Zamburlini A, van Amsterdam FT, Ratti E, Ursini F.
    Arch Biochem Biophys; 1992 Sep 01; 297(2):265-70. PubMed ID: 1497346
    [Abstract] [Full Text] [Related]

  • 13. Effect of serum withdrawal on the contribution of L-type calcium channels (CaV1.2) to intracellular Ca2+ responses and chemotaxis in cultured human vascular smooth muscle cells.
    Patel MK, Clunn GF, Lymn JS, Austin O, Hughes AD.
    Br J Pharmacol; 2005 Jul 01; 145(6):811-7. PubMed ID: 15880143
    [Abstract] [Full Text] [Related]

  • 14. Vascular reactivity: a measurement of calcium channel blockade.
    Elliott HL.
    J Hum Hypertens; 1995 Mar 01; 9 Suppl 1():S29-32. PubMed ID: 7783111
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity.
    Shibata S, Satake N, Kodama I, Hester RK, Wang CG, Jino H, Hojo M, Tatsumi H, Gandhi V, Jones DJ.
    Eur J Pharmacol; 1991 Oct 22; 203(3):337-44. PubMed ID: 1773820
    [Abstract] [Full Text] [Related]

  • 16. Selective inhibitory action of Biginelli-type dihydropyrimidines on depolarization-induced arterial smooth muscle contraction.
    Cernecka H, Veizerova L, Mensikova L, Svetlik J, Krenek P.
    J Pharm Pharmacol; 2012 May 22; 64(5):735-41. PubMed ID: 22471370
    [Abstract] [Full Text] [Related]

  • 17. Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: comparison with nifedipine and amlodipine.
    Hirano T, Ohura M, Orito K, Fujiki H, Miyakoda G, Mori T.
    Eur J Pharmacol; 1997 Apr 18; 324(2-3):201-4. PubMed ID: 9145772
    [Abstract] [Full Text] [Related]

  • 18. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A, Ukai Y, Matsuzaki T, Taniguchi N, Hayashi S, Kano S, Kimura Y, Kimura K, Enomoto H.
    Arzneimittelforschung; 1986 Sep 18; 36(9):1323-8. PubMed ID: 3790181
    [Abstract] [Full Text] [Related]

  • 19. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
    Fleckenstein A, Frey M, Zorn J, Fleckenstein-Grün G.
    Am J Cardiol; 1989 Nov 07; 64(17):21I-34I. PubMed ID: 2530884
    [Abstract] [Full Text] [Related]

  • 20. Potassium depolarization elevates cytosolic free calcium concentration in rat anterior pituitary cells through 1,4-dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels.
    Meier K, Knepel W, Schöfl C.
    Endocrinology; 1988 Jun 07; 122(6):2764-70. PubMed ID: 2453348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.